{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T02:01:19Z","timestamp":1774144879210,"version":"3.50.1"},"reference-count":23,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.2176\/jns-nmc.2021-0297","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T22:14:03Z","timestamp":1645568043000},"page":"13-17","source":"Crossref","is-referenced-by-count":3,"title":["Ischemic Stroke with Multiple Cerebral Artery Stenosis in a Patient with an Anaplastic Astrocytoma during Bevacizumab Treatment: A Case Report"],"prefix":"10.2176","volume":"9","author":[{"given":"Mariko","family":"NODA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University"},{"name":"Department of Neurosurgery, Japanese Red Cross Musashino Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"INAJI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"KARAKAMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukika","family":"ARAI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masae","family":"KUROHA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"TAMURA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"TANAKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketoshi","family":"MAEHARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mikami T, Suzuki H, Komatsu K, Mikuni N: Influence of inflammatory disease on the pathophysiology of moyamoya disease and quasi-moyamoya disease. <i>Neurol Med Chir (Tokyo)<\/i> 59: 361-370, 2019","DOI":"10.2176\/nmc.ra.2019-0059"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Moens S, Goveia J, Stapor PC, Cantelmo AR, Carmeliet P: The multifaceted activity of VEGF in angiogenesis-implications for therapy responses. <i>Cytokine Growth Factor Rev<\/i> 25: 473-482, 2014","DOI":"10.1016\/j.cytogfr.2014.07.009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Totzeck M, Mincu RI, Rassaf T: Cardiovascular adverse events in patients with cancer treated with bevacizumab: a meta-analysis of more than 20 000 patients. <i>J Am Heart Assoc<\/i> 6: e006278, 2017","DOI":"10.1161\/JAHA.117.006278"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Scappaticci FA, Skillings JR, Holden SN, et al.: Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. <i>J Natl Cancer Inst<\/i> 99: 1232-1239, 2007","DOI":"10.1093\/jnci\/djm086"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Zuo PY, Chen XL, Liu YW, Xiao CL, Liu CY: Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis. <i>PLoS One<\/i> 9: e102484, 2014","DOI":"10.1371\/journal.pone.0102484"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM: Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. <i>J Neurooncol<\/i> 105: 281-289, 2011","DOI":"10.1007\/s11060-011-0579-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lai A, Tran A, Nghiemphu PL, et al.: Phase II Study of Bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. <i>J Clin Oncol<\/i> 29: 142-148, 2011","DOI":"10.1200\/JCO.2010.30.2729"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nagane M, Hayashi Y, Shimizu A, Ura M, Nishikawa R: Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study. <i>Jpn J Clin Oncol<\/i> 49: 1016-1023, 2019","DOI":"10.1093\/jjco\/hyz125"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Seidel C, Hentschel B, Simon M, et al.: A comprehensive analysis of vascular complications in 3889 glioma patients from the German Glioma Network. <i>J Neurol<\/i> 260: 847-855, 2013","DOI":"10.1007\/s00415-012-6718-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Giantonio BJ, Catalano PJ, Meropol NJ, et al.: Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. <i>J Clin Oncol<\/i> 25: 1539-1544, 2007","DOI":"10.1200\/JCO.2006.09.6305"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Allegra CJ, Yothers G, O&apos;Connell MJ, et al.: Initial safety report of NSABP C-08: a randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer. <i>J Clin Oncol<\/i> 27: 3385-3390, 2009","DOI":"10.1200\/JCO.2009.21.9220"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Price TJ, Zannino D, Wilson K, et al.: Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C. <i>Ann Oncol<\/i> 23: 1531-1536, 2012","DOI":"10.1093\/annonc\/mdr488"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Turco LC, Ferrandina G, Vargiu V, et al.: Extreme complications related to bevacizumab use in the treatment of ovarian cancer: a case series from a III level referral centre and review of the literature. <i>Ann Transl Med<\/i> 8: 1687, 2020","DOI":"10.21037\/atm-20-4448"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Cameron D, Brown J, Dent R, et al.: Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial. <i>Lancet Oncol<\/i> 14: 933-942, 2013","DOI":"10.1016\/S1470-2045(13)70335-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Miller K, Wang M, Gralow J, et al.: Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. <i>N Engl J Med<\/i> 357: 2666-2676, 2007","DOI":"10.1056\/NEJMoa072113"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kelly WK, Halabi S, Carducci M, et al.: Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401. <i>J Clin Oncol<\/i> 30: 1534-1540, 2012","DOI":"10.1200\/JCO.2011.39.4767"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Rini BI, Halabi S, Rosenberg JE, et al.: Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206. <i>J Clin Oncol<\/i> 28: 2137-2143, 2012","DOI":"10.1200\/JCO.2009.26.5561"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Zachary I: Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. <i>Am J Physiol Cell Physiol<\/i> 280: C1375-C1386, 2001","DOI":"10.1152\/ajpcell.2001.280.6.C1375"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. <i>Endocr Rev<\/i> 25: 581-611, 2004","DOI":"10.1210\/er.2003-0027"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Seet RCS, Rabinstein AA, Lindell PE, Uhm JH, Wijdicks EF: Cerebrovascular events after bevacizumab treatment: an early and severe complication. <i>Neurocrit Care<\/i> 15: 421-427, 2011","DOI":"10.1007\/s12028-011-9552-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Pilotto C, Beshlawi I, Thomas A, Grundy RG: Vascular stenosis in a child with visual pathway glioma treated with bevacizumab: a case report and review of literature. <i>Childs Nerv Syst<\/i> 34: 781-785, 2018","DOI":"10.1007\/s00381-017-3676-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Plummer C, Henderson RD, O&apos;Sullivan JD, Read SJ: Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review. <i>Stroke<\/i> 42: 2410-2418, 2011","DOI":"10.1161\/STROKEAHA.111.615203"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Gujral DM, Shah BN, Chahal NS, Senior R, Harrington KJ, Nutting CM: Clinical features of radiation-induced carotid atherosclerosis. <i>Clin Oncol<\/i> 26: 94-102, 2014","DOI":"10.1016\/j.clon.2013.10.002"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/9\/0\/9_2021-0297\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:36:42Z","timestamp":1715233002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/9\/0\/9_2021-0297\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":23,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2021-0297","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,31]]},"article-number":"2021-0297"}}